2023 Q1 Form 10-K Financial Statement
#000095017023010428 Filed on March 29, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $174.0K | $106.0K | $1.180M |
YoY Change | -28.69% | -82.09% | -32.73% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $3.967M | $3.770M | $16.56M |
YoY Change | -7.12% | -2.43% | 7.56% |
% of Gross Profit | |||
Research & Development | $12.45M | $13.64M | $52.04M |
YoY Change | 6.07% | 14.87% | 10.43% |
% of Gross Profit | |||
Depreciation & Amortization | $576.0K | $613.0K | $2.500M |
YoY Change | -4.16% | 0.33% | 4.17% |
% of Gross Profit | |||
Operating Expenses | $16.42M | $17.41M | $68.60M |
YoY Change | 39.86% | 10.62% | 9.73% |
Operating Profit | -$16.24M | -$67.42M | |
YoY Change | 3.03% | 10.95% | |
Interest Expense | $1.000K | $610.0K | $2.000K |
YoY Change | -98.48% | 933.9% | 0.0% |
% of Operating Profit | |||
Other Income/Expense, Net | $621.0K | -$3.000K | $1.272M |
YoY Change | 813.24% | 0.0% | -31900.0% |
Pretax Income | -$15.62M | -$16.70M | -$66.15M |
YoY Change | -0.48% | 10.65% | 9.22% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$15.62M | -$16.70M | -$66.15M |
YoY Change | -0.48% | 10.65% | 9.22% |
Net Earnings / Revenue | -8978.16% | -15750.94% | -5605.68% |
Basic Earnings Per Share | -$0.23 | -$0.92 | |
Diluted Earnings Per Share | -$0.23 | -$0.24 | -$0.92 |
COMMON SHARES | |||
Basic Shares Outstanding | 67.73M | 70.52M | 71.73M |
Diluted Shares Outstanding | 69.07M | 71.73M |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $57.37M | $77.63M | $77.63M |
YoY Change | -52.4% | -39.63% | -39.63% |
Cash & Equivalents | $25.54M | $15.86M | $15.86M |
Short-Term Investments | $31.83M | $61.77M | $61.77M |
Other Short-Term Assets | $4.991M | $175.0K | $2.153M |
YoY Change | 27.97% | -96.29% | -54.4% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $62.36M | $79.78M | $79.78M |
YoY Change | -49.88% | -40.15% | -40.15% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $6.885M | $7.323M | $21.68M |
YoY Change | -71.28% | -19.42% | -5.65% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Other Assets | $22.00K | $7.000K | $9.404M |
YoY Change | -99.8% | 133.33% | -9.66% |
Total Long-Term Assets | $31.08M | $31.08M | $31.08M |
YoY Change | -10.91% | -24.97% | -24.97% |
TOTAL ASSETS | |||
Total Short-Term Assets | $62.36M | $79.78M | $79.78M |
Total Long-Term Assets | $31.08M | $31.08M | $31.08M |
Total Assets | $93.44M | $110.9M | $110.9M |
YoY Change | -41.34% | -36.55% | -36.55% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.316M | $1.785M | $1.785M |
YoY Change | -3.86% | -8.18% | -8.18% |
Accrued Expenses | $2.421M | $5.290M | $9.442M |
YoY Change | -65.06% | 20.17% | 24.35% |
Deferred Revenue | $692.0K | $882.0K | |
YoY Change | 66.1% | ||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $14.00K | $13.00K | $13.00K |
YoY Change | 16.67% | 8.33% | 8.33% |
Total Short-Term Liabilities | $9.737M | $12.12M | $12.12M |
YoY Change | 0.76% | 20.26% | 20.26% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $1.000K | $4.000K | $4.000K |
YoY Change | -93.33% | -77.78% | -77.78% |
Other Long-Term Liabilities | $14.99M | $16.13M | $16.13M |
YoY Change | -13.52% | -7.16% | -7.16% |
Total Long-Term Liabilities | $14.99M | $16.13M | $16.13M |
YoY Change | -13.58% | -7.23% | -7.23% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $9.737M | $12.12M | $12.12M |
Total Long-Term Liabilities | $14.99M | $16.13M | $16.13M |
Total Liabilities | $24.73M | $28.26M | $28.26M |
YoY Change | -8.45% | 2.86% | 2.86% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$372.6M | -$357.0M | |
YoY Change | 21.53% | 22.73% | |
Common Stock | $443.9M | $442.3M | |
YoY Change | 0.94% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $2.518M | $2.518M | |
YoY Change | |||
Treasury Stock Shares | $4.197M | $4.197M | |
Shareholders Equity | $68.71M | $82.61M | $82.61M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $93.44M | $110.9M | $110.9M |
YoY Change | -41.34% | -36.55% | -36.55% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$15.62M | -$16.70M | -$66.15M |
YoY Change | -0.48% | 10.65% | 9.22% |
Depreciation, Depletion And Amortization | $576.0K | $613.0K | $2.500M |
YoY Change | -4.16% | 0.33% | 4.17% |
Cash From Operating Activities | -$21.51M | -$12.39M | -$56.89M |
YoY Change | 38.95% | -5.11% | 8.99% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $143.0K | $43.00K | $728.0K |
YoY Change | -70.02% | -125.0% | 7.22% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $30.41M | $14.90M | $59.08M |
YoY Change | 50.3% | -144.98% | -212.37% |
Cash From Investing Activities | $30.27M | $14.86M | $58.35M |
YoY Change | 53.2% | -144.62% | -209.57% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $0.00 | ||
YoY Change | -100.0% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 913.0K | -2.229M | -2.040M |
YoY Change | 591.67% | 1757.5% | -102.28% |
NET CHANGE | |||
Cash From Operating Activities | -21.51M | -12.39M | -56.89M |
Cash From Investing Activities | 30.27M | 14.86M | 58.35M |
Cash From Financing Activities | 913.0K | -2.229M | -2.040M |
Net Change In Cash | 9.678M | 239.0K | -577.0K |
YoY Change | 119.31% | -100.51% | -96.41% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$21.51M | -$12.39M | -$56.89M |
Capital Expenditures | $143.0K | $43.00K | $728.0K |
Free Cash Flow | -$21.65M | -$12.44M | -$57.62M |
YoY Change | 35.69% | -3.51% | 8.96% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | us-gaap |
Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
|
true | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2017Q3 | us-gaap |
Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
|
true | |
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001527599 | |
CY2017Q3 | us-gaap |
Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
|
true | |
CY2022 | us-gaap |
Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
|
true | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2021 | us-gaap |
Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
|
greater than 50% | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2021Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
||
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
001-37566 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
SYNLOGIC, INC. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
26-1824804 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
301 Binney St | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 402 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Cambridge | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MA | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
02142 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
617 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
401-9975 | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 per share | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
SYBX | |
CY2022 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
41500000 | |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
67728025 | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
185 | |
CY2022 | dei |
Auditor Name
AuditorName
|
KPMG LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Boston, Massachusetts, U.S. | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
15861000 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
16438000 | |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
61768000 | |
CY2021Q4 | us-gaap |
Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
|
112150000 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2153000 | |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4721000 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
79782000 | |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
133309000 | |
CY2021Q4 | us-gaap |
Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
|
8041000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7323000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9088000 | |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
14356000 | |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
13889000 | |
CY2022Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
1097000 | |
CY2021Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
1097000 | |
CY2022Q4 | sybx |
Prepaid Research And Development Noncurrent
PrepaidResearchAndDevelopmentNoncurrent
|
8300000 | |
CY2021Q4 | sybx |
Prepaid Research And Development Noncurrent
PrepaidResearchAndDevelopmentNoncurrent
|
9309000 | |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
7000 | |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3000 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
110865000 | |
CY2021Q4 | us-gaap |
Assets
Assets
|
174736000 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1785000 | |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1944000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
5290000 | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4402000 | |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
882000 | |
CY2021Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
531000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
4152000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3191000 | |
CY2022Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
13000 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
12000 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
12122000 | |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10080000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
16129000 | |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
17372000 | |
CY2022Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
4000 | |
CY2021Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
18000 | |
CY2022Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
16133000 | |
CY2021Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
17390000 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
70933140 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
66736251 | |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
69698844 | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
69698844 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
71000 | |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
70000 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
442237000 | |
CY2021Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
438113000 | |
CY2022Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-161000 | |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-45000 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-357019000 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-290872000 | |
CY2022Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
4196889 | |
CY2021Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
0 | |
CY2022Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
2518000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
82610000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
147266000 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
110865000 | |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
174736000 | |
CY2022 | us-gaap |
Revenues
Revenues
|
1180000 | |
CY2021 | us-gaap |
Revenues
Revenues
|
1754000 | |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
52044000 | |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
47127000 | |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
16555000 | |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
15392000 | |
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
68599000 | |
CY2021 | us-gaap |
Operating Expenses
OperatingExpenses
|
62519000 | |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-67419000 | |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-60765000 | |
CY2022 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
1267000 | |
CY2021 | us-gaap |
Investment Income Nonoperating
InvestmentIncomeNonoperating
|
210000 | |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
2000 | |
CY2021 | us-gaap |
Interest Expense
InterestExpense
|
2000 | |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
7000 | |
CY2021 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-4000 | |
CY2022 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1272000 | |
CY2021 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
204000 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-66147000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-60561000 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.92 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.92 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.09 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.09 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
71725479 | |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
71725479 | |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
55329711 | |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
55329711 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-66147000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-60561000 | |
CY2022 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-116000 | |
CY2021 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-59000 | |
CY2022 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-66263000 | |
CY2021 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-60620000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
115135000 | |
CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
81039000 | |
CY2021 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
280000 | |
CY2021 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
94000 | |
CY2021 | sybx |
Stock Issued During Period Value Shares Withholding
StockIssuedDuringPeriodValueSharesWithholding
|
73000 | |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3361000 | |
CY2021 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-59000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-60561000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
147266000 | |
CY2022 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
2518000 | |
CY2022 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
61000 | |
CY2022 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
1000 | |
CY2022 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
137000 | |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3639000 | |
CY2022 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-116000 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-66147000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
82610000 | |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-66147000 | |
CY2021 | us-gaap |
Profit Loss
ProfitLoss
|
-60561000 | |
CY2022 | us-gaap |
Depreciation
Depreciation
|
2520000 | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
2443000 | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3639000 | |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3361000 | |
CY2022 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
772000 | |
CY2021 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-261000 | |
CY2022 | sybx |
Reduction In Carrying Amount Of Operating Lease Right Of Use Asset
ReductionInCarryingAmountOfOperatingLeaseRightOfUseAsset
|
3149000 | |
CY2021 | sybx |
Reduction In Carrying Amount Of Operating Lease Right Of Use Asset
ReductionInCarryingAmountOfOperatingLeaseRightOfUseAsset
|
2098000 | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-2568000 | |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1681000 | |
CY2022 | sybx |
Increase Decrease In Prepaid Research And Development Net Of Current Portion
IncreaseDecreaseInPrepaidResearchAndDevelopmentNetOfCurrentPortion
|
1009000 | |
CY2021 | sybx |
Increase Decrease In Prepaid Research And Development Net Of Current Portion
IncreaseDecreaseInPrepaidResearchAndDevelopmentNetOfCurrentPortion
|
281000 | |
CY2022 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
4000 | |
CY2021 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-1000 | |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
697000 | |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
538000 | |
CY2022 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
351000 | |
CY2021 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
531000 | |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-3898000 | |
CY2021 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-2701000 | |
CY2022 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
0 | |
CY2021 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-131000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-56888000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-52198000 | |
CY2022 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
82787000 | |
CY2021 | us-gaap |
Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
167866000 | |
CY2022 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
141866000 | |
CY2021 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
114022000 | |
CY2022 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
0 | |
CY2021 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
1270000 | |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
728000 | |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
679000 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
58351000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-53253000 | |
CY2022 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
13000 | |
CY2021 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
8000 | |
CY2022 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
0 | |
CY2021 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
73000 | |
CY2022 | sybx |
Proceeds From Employee Stock Purchases And Exercise Of Stock Options
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptions
|
198000 | |
CY2021 | sybx |
Proceeds From Employee Stock Purchases And Exercise Of Stock Options
ProceedsFromEmployeeStockPurchasesAndExerciseOfStockOptions
|
374000 | |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
81042000 | |
CY2022 | us-gaap |
Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
|
2518000 | |
CY2021 | us-gaap |
Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
|
0 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2040000 | |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
89382000 | |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-577000 | |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-16069000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
17535000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
33604000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
16958000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
17535000 | |
CY2022 | sybx |
Noncash Purchase Of Property Plant And Equipment In Accounts Payable And Accrued Liabilities Adjustments
NoncashPurchaseOfPropertyPlantAndEquipmentInAccountsPayableAndAccruedLiabilitiesAdjustments
|
27000 | |
CY2021 | sybx |
Noncash Purchase Of Property Plant And Equipment In Accounts Payable And Accrued Liabilities Adjustments
NoncashPurchaseOfPropertyPlantAndEquipmentInAccountsPayableAndAccruedLiabilitiesAdjustments
|
40000 | |
CY2022 | sybx |
Assets Acquired Under Operating Lease Obligation
AssetsAcquiredUnderOperatingLeaseObligation
|
3616000 | |
CY2021 | sybx |
Assets Acquired Under Operating Lease Obligation
AssetsAcquiredUnderOperatingLeaseObligation
|
460000 | |
CY2022 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
0 | |
CY2021 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
36000 | |
CY2022 | sybx |
Issuance Costs Included In Accounts Payable And Accrued Expenses
IssuanceCostsIncludedInAccountsPayableAndAccruedExpenses
|
6000 | |
CY2021 | sybx |
Issuance Costs Included In Accounts Payable And Accrued Expenses
IssuanceCostsIncludedInAccountsPayableAndAccruedExpenses
|
0 | |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2000 | |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
77600000 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-357000000.0 | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. On an on-going basis, the Company’s management evaluates its estimates, including those related to research and development accruals and prepaids, accrued expenses, contingencies, and investments. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</span></p> | |
CY2022 | us-gaap |
Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
|
three months or less | |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
15900000 | |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
16400000 | |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Financial instruments that potentially subject the Company to concentrations of credit risk include amounts held as cash, cash equivalents, marketable securities and restricted cash. The Company uses high quality, accredited financial institutions to maintain its balances, and accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. The Company has no financial instruments with off-balance sheet risk of loss.</span></p> | |
CY2022 | us-gaap |
Revenue Practical Expedient Remaining Performance Obligation Description
RevenuePracticalExpedientRemainingPerformanceObligationDescription
|
The Company recognizes as an asset the incremental costs of obtaining a contract with a customer if the costs are expected to be recovered. As a practical expedient, the Company recognizes the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that we otherwise would have recognized is one year or less. To date, the Company has not incurred any incremental costs of obtaining a contract with a customer | |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4721000 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
15861000 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
16438000 | |
CY2022Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
1097000 | |
CY2021Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
1097000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
16958000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
17535000 | |
CY2022 | sybx |
Fair Value Asset Liability Transfers Between Level1 Level2 And Level3 Amount
FairValueAssetLiabilityTransfersBetweenLevel1Level2AndLevel3Amount
|
0 | |
CY2021 | sybx |
Fair Value Asset Liability Transfers Between Level1 Level2 And Level3 Amount
FairValueAssetLiabilityTransfersBetweenLevel1Level2AndLevel3Amount
|
0 | |
CY2022 | us-gaap |
Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
|
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;font-style:italic;min-width:fit-content;">Impairment of Long‑Lived Assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Long‑lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. When such events occur, the Company compares the carrying amounts of the assets to their undiscounted expected future cash flows. If this comparison indicates that there is impairment, the amount of impairment is calculated as the difference between the carrying value and fair value of the asset. To date, </span><span style="font-size:10.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> such impairments have been recognized.</span></p> | |
CY2022 | us-gaap |
Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
|
0 | |
CY2022 | us-gaap |
Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
|
options to extend the lease when it is reasonably certain that option will be exercised | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P12M | |
CY2022 | us-gaap |
Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
|
greater than 50% | |
CY2022 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
CY2022Q4 | sybx |
Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
|
320000 | |
CY2021Q4 | sybx |
Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
|
2721000 | |
CY2022Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
771000 | |
CY2021Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
710000 | |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
175000 | |
CY2021Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
311000 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2153000 | |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
61929000 | |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
8000 | |
CY2022Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
169000 | |
CY2022Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
61768000 | |
CY2021Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
120236000 | |
CY2021Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
8000 | |
CY2021Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
53000 | |
CY2021Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
120191000 | |
CY2022Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
36600000 | |
CY2021Q4 | us-gaap |
Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
|
72200000 | |
CY2022Q4 | sybx |
Other Than Temporary Impairment Losses Investments Number Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossesInvestmentsNumberDebtSecuritiesAvailableForSale
|
0 | |
CY2022Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
887000 | |
CY2021Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
979000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
20463000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
19714000 | |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
13140000 | |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
10626000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7323000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9088000 | |
CY2022 | us-gaap |
Depreciation
Depreciation
|
2500000 | |
CY2021 | us-gaap |
Depreciation
Depreciation
|
2400000 | |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3401000 | |
CY2021Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3495000 | |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
152000 | |
CY2021Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
298000 | |
CY2022Q4 | sybx |
Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
|
1624000 | |
CY2021Q4 | sybx |
Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
|
336000 | |
CY2022Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
113000 | |
CY2021Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
273000 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
5290000 | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4402000 | |
CY2022 | sybx |
Number Of Votes Entitled To Each Share Of Common Stock
NumberOfVotesEntitledToEachShareOfCommonStock
|
1 | |
us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
0 | ||
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
81803000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
76802000 | |
CY2022Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
5928776 | |
CY2022Q4 | sybx |
Share Based Compensation By Share Based Arrangement Award Options Available For Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementAwardOptionsAvailableForAggregateIntrinsicValue
|
185500 | |
CY2021Q4 | sybx |
Share Based Compensation By Share Based Arrangement Award Options Available For Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementAwardOptionsAvailableForAggregateIntrinsicValue
|
1210026 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.16 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.42 | |
CY2022 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
3200000 | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
|
2800000 | |
CY2022Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
4900000 | |
CY2022 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y7M6D | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3600000 | |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3400000 | |
CY2022 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3639000 | |
CY2021 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3361000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
9118000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
7248000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
127000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
181000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
888000 | |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3639000 | |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3361000 | |
CY2022 | sybx |
Anticipated Completion Of Research And Development Projects Period
AnticipatedCompletionOfResearchAndDevelopmentProjectsPeriod
|
P2Y | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-66147000 | |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-60561000 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
71725479 | |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
71725479 | |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
55329711 | |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
55329711 | |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.92 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.92 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.09 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.09 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
|
591000 | |
CY2022Q4 | sybx |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
5541000 | |
CY2021Q4 | sybx |
Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
|
5618000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2516000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
2396000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
1165000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
1197000 | |
CY2022Q4 | sybx |
Deferred Tax Assets Amortizable Research Expenditures
DeferredTaxAssetsAmortizableResearchExpenditures
|
12000000 | |
CY2021Q4 | sybx |
Deferred Tax Assets Amortizable Research Expenditures
DeferredTaxAssetsAmortizableResearchExpenditures
|
0 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
363000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
238000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
113521000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
94271000 | |
CY2022Q4 | sybx |
Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
|
3922000 | |
CY2021Q4 | sybx |
Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
|
3794000 | |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
3922000 | |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
3794000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
109599000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
90477000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
109600000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
90500000 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.06 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.06 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
-0.01 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
0 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.03 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.02 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.29 | |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.29 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
90477000 | |
CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
72791000 | |
CY2022 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-19122000 | |
CY2021 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
-17686000 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
109599000 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
90477000 | |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
302500000 | |
CY2022Q3 | sybx |
Corporate Minimum Tax Effect Percentage
CorporateMinimumTaxEffectPercentage
|
0.15 | |
CY2022Q4 | sybx |
Excise Tax Percentage
ExciseTaxPercentage
|
0.01 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2022Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | |
CY2021Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | |
CY2022 | us-gaap |
Income Tax Examination Description
IncomeTaxExaminationDescription
|
In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. Tax years from 2019 to the present are open to examination under the statute. | |
CY2022Q4 | sybx |
Repurchase Of Common Stock
RepurchaseOfCommonStock
|
4196889 | |
CY2022Q4 | sybx |
Aggregate Purchase
AggregatePurchase
|
2500000 | |
CY2022Q4 | sybx |
Aggregate Purchase Per Share
AggregatePurchasePerShare
|
0.60 | |
CY2017Q3 | sybx |
Rentable Space Under Lease Agreement
RentableSpaceUnderLeaseAgreement
|
41346 | |
CY2017Q3 | sybx |
Operating Leases Rent Expense Annual Rental Payments
OperatingLeasesRentExpenseAnnualRentalPayments
|
3400000 | |
CY2017Q3 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P10Y | |
CY2017Q3 | sybx |
Tenant Improvement Investment Obligation
TenantImprovementInvestmentObligation
|
2900000 | |
CY2017Q3 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
1000000.0 | |
CY2017Q3 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P5Y | |
CY2018 | sybx |
Agreement Expiration Date
AgreementExpirationDate
|
2022-12-31 | |
CY2022 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
5500000 | |
CY2021 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
4400000 | |
CY2022 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
4812000 | |
CY2021 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
3824000 | |
CY2022 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
1409000 | |
CY2021 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
1500000 | |
CY2022 | sybx |
Operating And Variable Lease Cost
OperatingAndVariableLeaseCost
|
6221000 | |
CY2021 | sybx |
Operating And Variable Lease Cost
OperatingAndVariableLeaseCost
|
5324000 | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.083 | |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.080 | |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P5Y1M6D | |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P6Y3M18D | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
5626000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
4749000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
3792000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
3905000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
4022000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
|
2667000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
24761000 | |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
4480000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
20281000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
4152000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
16129000 | |
CY2020 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
0.50 | |
CY2020 | us-gaap |
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
|
0.04 | |
CY2020 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.02 | |
CY2021 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
0.50 | |
CY2021 | us-gaap |
Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
|
0.06 | |
CY2021 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.03 | |
CY2022 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
500000 | |
CY2021 | us-gaap |
Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
|
300000 |